[1]
“SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) DISCONTINUATION SYNDROME: STRATEGIES FOR MANAGING AND MINIMIZING SYMPTOMS: AN INTEGRATIVE REVIEW”, REMUNOM, vol. 21, no. 02, pp. 1–16, Dec. 2025, doi: 10.61164/eepm2q42.